gland pharma glp-1 manufacturing capacity India's pharmaceutical industry is witnessing another massive strategic move 💊📈 Anupam Rasayan plans to acquire up to 43% stake in Bliss GVS in a ₹1,369 crore deal, signaling stronger expansion, integrated GLP-1 Receptor Agonist Market Size

& Wilk, S

Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets

#CardiovascularDrugs #Cardiology #HeartHealth #PharmaceuticalIndustry #CardiovascularDisease #PharmaInnovation To view or add a comment, sign in : : The biosimilars market is expected to reach USD 72.29 billion by 2035 from USD 35.04 billion in 2025, at a CAGR of 7.5% during the forecast period

Gros R, You X, Baggio LL, Kabir MG, Sadi AM, Mungrue IN, et al

The True Meaning of Patient Autonomy Patient autonomy is the right to make informed decisions about your health